Clinical trials: COVID-19 Confirmed Cases
Covid19, Contact Case
Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT)
The hypothesis is that from a cluster defined by a confirmed positive case of COVID-19 and its contact cases, it is possible to study the different expressions and clinical evolutions of COVID-19 infection and to explore the…
- Trial name
- COVIDCOLLECT (NCT04597736)
- Testing
- Biological collection with nasopharyngeal samples, saliva, blood, stool and urine
- Where
- France
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University Hospital, Clermont-Ferrand
COVID-19 Confirmed Cases, COVID-19 Mortality
COVID - AirPollution
Epidemiological data have related particulate matter (PM), nitrogen dioxide (NO2) and ozone (O3) to COVID-19 morbidity and mortality at the population level.
- Trial name
- NCT04463862
- Where
- 8 sites in Belgium, France
- Volunteers
- 660 people
- Sponsor
- University Hospital, Strasbourg, France
Covid-19
Canadian COVID-19 Emergency Department Registry
Coronavirus Disease 2019 (COVID -19) is the largest public health crisis in over a century. There is an urgent need for high-quality population-level data to understand modifiable risks for disease severity, transmissibility, and…
- Trial name
- CCEDRRN (NCT04702945)
- Where
- 50 sites in Canada
- Volunteers
- 200,000 people
- Sponsor
- University of British Columbia
COVID-19, SARS-CoV-2 Infection
Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
Main goal: To generate information on the efficacy and safety of Dialyzable Leukocyte Extract (DLE) as an aid in the treatment of patients with acute respiratory infection (suspected or confirmed cases of COVID-19).
- Trial name
- FUTURE-T (NCT04379479)
- Testing
- Dialyzable Leukocyte Extract
- Where
- Mexico
- Volunteers
- 562 people
- Sponsor
- National Polytechnic Institute, Mexico
Coronavirus Infection
Serologic Testing of Household Contacts of Confirmed Cases of COVID-19
SARS-CoV-2 has now crossed the 1 million number of cases and tens of thousands of deaths. It´s R0 has been calculated between 2 and 5.7 solely based on clinical symptoms but it is estimated to likely be higher.
- Trial name
- NCT04393142
- Where
- Mexico
- Volunteers
- 96 people, healthy volunteers welcome
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
Primary Care : Suspected and Confirmed Cases of COVID-19, Primary Health Care
Primary Care in AURA for COVID-19
As few data are available on the epidemiology of the COVID-19 in primary care, the project aims to implement a practice-based surveillance network based on multiprofessional health homes in the French region Auvergne-Rhône-Alpes…
- Conditions
- Primary Care : Suspected and Confirmed Cases of COVID-19, Primary Health Care, COVID-19 Pandemic
- Trial name
- SOPRAC (NCT05124145)
- Testing
- No intervention (surveillance system)
- Where
- France
- Volunteers
- 7,000 people
- Sponsor
- Research on Healthcare Performance Lab U1290
COVID-19, SARS-CoV-2 Infection
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
This is a phase II pilot, international, multicenter, randomized, double-blind, placebo-controlled study that aims to evaluate the safety and preliminary efficacy of rSIFN-co nasal spray in healthy subjects in close contact with…
- Trial name
- NCT05485584
- Testing
- rSIFN-co Nasal Spray
- Where
- 2 sites in Philippines
- Volunteers
- 188 people, healthy volunteers welcome
- Sponsor
- Sichuan Huiyang Life Science and Technology Corporation
Covid-19
Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients
A large number of Health Care Workers (HCWs) would be potentially getting exposed to COVID19. Some of them would be asymptomatic or may get subclinical symptoms.
- Trial name
- NCT04368884
- Where
- India
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Max Healthcare Insititute Limited
COVID-19
Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention
This study is a research project to evaluate the efficacy of hydroxychloroquine for post-exposure prophylaxis and early treatment of Covid-19.
- Trial name
- HCQ4COV19 (NCT04304053)
- Testing
- Treatment and prophylaxis, Standard Public Health measures
- Where
- Spain
- Volunteers
- 2,300 people, healthy volunteers welcome
- Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
COVID-19
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19)
In December 2019, a group of patients with pneumonia of unknown cause was identified in Wuhan, in the Hubei province, China. Despite the need of target specific therapeutic options for COVID-19, until now there is no proof of…
- Trial name
- COALITION-V (NCT04466540)
- Testing
- Hydroxychloroquine
- Where
- 69 sites in Brazil
- Volunteers
- 1,372 people
- Sponsor
- Hospital Alemão Oswaldo Cruz